Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes.
BACKGROUND Insulin resistance, metabolic dysfunction, inflammation, and vascular impairment characterize Type 2 Diabetes Mellitus (T2DM). Mesenchymal stem cells (MSCs) have shown promise in preclinical studies. However, their variable efficacy in human settings warrants strategies to enhance their therapeutic potency....